![Sarah Foster](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sarah Foster
Personalreferent bei MINERALYS THERAPEUTICS, INC.
Aktive Positionen von Sarah Foster
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MINERALYS THERAPEUTICS, INC. | Personalreferent | - | - |
Karriereverlauf von Sarah Foster
Ehemalige bekannte Positionen von Sarah Foster
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Teva Pharmaceuticals USA, Inc.
![]() Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | - | - |
GALERA THERAPEUTICS, INC. | Personalreferent | - | - |
TREVENA, INC. | Personalreferent | - | - |
NEOS THERAPEUTICS, INC. | Personalreferent | 01.08.2019 | - |
Ausbildung von Sarah Foster
Arizona State University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Human Resources Officer | 4 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
MINERALYS THERAPEUTICS, INC. | Health Technology |
GALERA THERAPEUTICS, INC. | Health Technology |
TREVENA, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Neos Therapeutics, Inc.
![]() Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |
Teva Pharmaceuticals USA, Inc.
![]() Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Health Technology |
- Börse
- Insiders
- Sarah Foster
- Erfahrung